AstraZeneca's global biologics R&D arm MedImmune has entered into a five-year multi-project research collaboration with the University of Sheffield to carry out breakthrough research in cell factory technology process.
With the in cell factory technology, living cells can be controlled and manipulated to make specific proteins with therapeutic benefits.